Synthetic catalytic scavenger - Eukarion/IsoTis
Alternative Names: Oxyscav; Reactive oxygen species scavenger - Eukarion/IsoTisLatest Information Update: 08 Jan 2003
Price :
$50 *
At a glance
- Originator Eukarion
- Developer IsoTis SA
- Class Small molecules
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Radiation-induced skin damage
Most Recent Events
- 08 Jan 2003 Modex Therapeutics has merged with IsoTis NV to form IsoTis SA
- 07 Jan 2003 Discontinued - Preclinical for Radiation-induced skin damage in USA (Topical)
- 17 Jan 2002 Modex Therapeutics has submitted a pre-IND package to the US FDA for Oxyscav in patients with breast cancer